Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Free Cash Flow (2010 - 2026)

Exelixis (EXEL) posted quarterly Free Cash Flow of $250.3 million for Q2 2026, up 20.07% year-over-year from $208.5 million in Q2 2025, and down 24.68% quarter-over-quarter from $332.4 million in Q1 2026.

Analysis

Exelixis (EXEL) Free Cash Flow (2010 - 2026) Analysis & Trends

Exelixis' Free Cash Flow history runs 17 years deep, the most recent figure standing at $250.3 million for Q2 2026.

  • In Q2 2026, Free Cash Flow rose 20.07% year-over-year to $250.3 million; the TTM figure through Apr 2026 stood at $917.7 million (up 11.79% YoY), while the FY2026 annual figure was $875.8 million, up 30.42% from the prior year.
  • Free Cash Flow for Q2 2026 stood at $250.3 million, down from $332.4 million in the prior quarter.
  • The five-year high for Free Cash Flow was $332.4 million in Q1 2026, with the low at -$2.6 million in Q4 2023.
  • The 5-year median for Free Cash Flow is $113.0 million (2024), against an average of $142.7 million.
  • The sharpest annual moves came in 2023 and 2025: Free Cash Flow tumbled 104.01% in 2023, then soared 9315.52% in 2025.
  • Exelixis' Free Cash Flow stood at $64.0 million in 2022, then sank by 104.01% to -$2.6 million in 2023, then jumped by 10362.91% to $263.1 million in 2024, then advanced by 9.77% to $288.8 million in 2025, then retreated by 13.33% to $250.3 million in 2026.
  • Business Quant data shows EXEL's Free Cash Flow at $250.3 million in Q2 2026, $332.4 million in Q1 2026, and $288.8 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 300.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 300.93 Mn
Apr 3, 2026 250.34 Mn
Jan 2, 2026 332.36 Mn
Oct 3, 2025 288.84 Mn
Jul 4, 2025 46.16 Mn
Apr 4, 2025 208.49 Mn
Jan 3, 2025 236.29 Mn
Sep 27, 2024 263.14 Mn
Jun 28, 2024 112.98 Mn
Mar 29, 2024 59.13 Mn
Dec 29, 2023 -2.56 Mn
Sep 29, 2023 107.99 Mn
Jun 30, 2023 115.04 Mn
Mar 31, 2023 72.38 Mn
Dec 30, 2022 63.98 Mn
Sep 30, 2022 105.03 Mn
Jul 1, 2022 23.79 Mn
Apr 1, 2022 142.11 Mn
Dec 31, 2021 90.49 Mn
Oct 1, 2021 68.81 Mn